These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 9491508)
1. Local and systemic responses against ricin toxin promoted by toxoid or peptide vaccines alone or in liposomal formulations. Griffiths GD; Bailey SC; Hambrook JL; Keyte MP Vaccine; 1998 Mar; 16(5):530-5. PubMed ID: 9491508 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the quality of protection elicited by toxoid and peptide liposomal vaccine formulations against ricin as assessed by markers of inflammation. Griffiths GD; Phillips GJ; Bailey SC Vaccine; 1999 Jun; 17(20-21):2562-8. PubMed ID: 10418903 [TBL] [Abstract][Full Text] [Related]
3. Liposomally-encapsulated ricin toxoid vaccine delivered intratracheally elicits a good immune response and protects against a lethal pulmonary dose of ricin toxin. Griffiths GD; Bailey SC; Hambrook JL; Keyte M; Jayasekera P; Miles J; Williamson E Vaccine; 1997 Dec; 15(17-18):1933-9. PubMed ID: 9413104 [TBL] [Abstract][Full Text] [Related]
4. Protection against inhalation toxicity of ricin and abrin by immunisation. Griffiths GD; Lindsay CD; Allenby AC; Bailey SC; Scawin JW; Rice P; Upshall DG Hum Exp Toxicol; 1995 Feb; 14(2):155-64. PubMed ID: 7779439 [TBL] [Abstract][Full Text] [Related]
5. Intranasal stimulation of long-lasting immunity against aerosol ricin challenge with ricin toxoid vaccine encapsulated in polymeric microspheres. Yan C; Rill WL; Malli R; Hewetson J; Naseem H; Tammariello R; Kende M Vaccine; 1996 Aug; 14(11):1031-8. PubMed ID: 8879098 [TBL] [Abstract][Full Text] [Related]
6. Enhancement of intranasal vaccination with recombinant chain A ricin vaccine (rRV) in mice by the mucosal adjuvants LTK63 and LTR72. Kende M; Tan X; Wlazlowski C; Williams R; Lindsey C; Del Giudice G Vaccine; 2007 Apr; 25(16):3219-27. PubMed ID: 17343960 [TBL] [Abstract][Full Text] [Related]
7. Enhancement of intranasal vaccination in mice with deglycosylated chain A ricin by LTR72, a novel mucosal adjuvant. Kende M; Del Giudice G; Rivera N; Hewetson J Vaccine; 2006 Mar; 24(12):2213-21. PubMed ID: 16325310 [TBL] [Abstract][Full Text] [Related]
8. Oral immunization of mice with ricin toxoid vaccine encapsulated in polymeric microspheres against aerosol challenge. Kende M; Yan C; Hewetson J; Frick MA; Rill WL; Tammariello R Vaccine; 2002 Feb; 20(11-12):1681-91. PubMed ID: 11858879 [TBL] [Abstract][Full Text] [Related]
9. Strong protection against ricin challenge induced by a novel modified ricin A-chain protein in mouse model. Zhang T; Yang H; Kang L; Gao S; Xin W; Yao W; Zhuang X; Ji B; Wang J Hum Vaccin Immunother; 2015; 11(7):1779-87. PubMed ID: 26038805 [TBL] [Abstract][Full Text] [Related]
10. Dependence of ricin toxoid vaccine efficacy on the structure of poly(lactide-co-glycolide) microparticle carriers. Yan C; Rill WL; Malli R; Hewetson J; Tammariello R; Kende M Vaccine; 1995 May; 13(7):645-51. PubMed ID: 7668034 [TBL] [Abstract][Full Text] [Related]
11. RiVax, a recombinant ricin subunit vaccine, protects mice against ricin delivered by gavage or aerosol. Smallshaw JE; Richardson JA; Vitetta ES Vaccine; 2007 Oct; 25(42):7459-69. PubMed ID: 17875350 [TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of diphtheria toxoid and poly(I:C) loaded cationic liposomes after hollow microneedle-mediated intradermal injection in mice. Du G; Leone M; Romeijn S; Kersten G; Jiskoot W; Bouwstra JA Int J Pharm; 2018 Aug; 547(1-2):250-257. PubMed ID: 29870743 [TBL] [Abstract][Full Text] [Related]
13. Preclinical toxicity and efficacy testing of RiVax, a recombinant protein vaccine against ricin. Smallshaw JE; Richardson JA; Pincus S; Schindler J; Vitetta ES Vaccine; 2005 Sep; 23(39):4775-84. PubMed ID: 15961194 [TBL] [Abstract][Full Text] [Related]
15. Liposomal Aerosols of Nitric Oxide (NO) Donor as a Long-Acting Substitute for the Ultra-Short-Acting Inhaled NO in the Treatment of PAH. Nahar K; Rashid J; Absar S; Al-Saikhan FI; Ahsan F Pharm Res; 2016 Jul; 33(7):1696-710. PubMed ID: 27048347 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of Liposomal Monensin on the Enhancement of the Antitumour Activity of Liposomal Ricin in Human Epidermoid Carcinoma (KB) Cells. Tyagi N; Rathore SS; Ghosh PC Indian J Pharm Sci; 2013 Jan; 75(1):16-22. PubMed ID: 23901156 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of peptide based epsilon toxin vaccine by covalent anchoring to tetanus toxoid. Kaushik H; Dixit A; Garg LC Anaerobe; 2018 Oct; 53():50-55. PubMed ID: 29920342 [TBL] [Abstract][Full Text] [Related]
18. Protective effect of two recombinant ricin subunit vaccines in the New Zealand white rabbit subjected to a lethal aerosolized ricin challenge: survival, immunological response, and histopathological findings. McLain DE; Lewis BS; Chapman JL; Wannemacher RW; Lindsey CY; Smith LA Toxicol Sci; 2012 Mar; 126(1):72-83. PubMed ID: 21987460 [TBL] [Abstract][Full Text] [Related]
19. Co-delivery of a CD4 T cell helper epitope via covalent liposome attachment with a surface-arrayed B cell target antigen fosters higher affinity antibody responses. Elbahnasawy MA; Donius LR; Reinherz EL; Kim M Vaccine; 2018 Oct; 36(41):6191-6201. PubMed ID: 30197285 [TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin A antibodies against ricin A and B subunits protect epithelial cells from ricin intoxication. Mantis NJ; McGuinness CR; Sonuyi O; Edwards G; Farrant SA Infect Immun; 2006 Jun; 74(6):3455-62. PubMed ID: 16714576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]